Schedule 13G ownership disclosure

REIN THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A204

Event date: 2024-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,812,627
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019231-24-000016
Form type
SC 13G
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Mar 05, 2024
Reporting period
Feb 28, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub